Prescription Drug Safety
The Senate Health, Education, Labor and Pensions Committee heard testimony from medical experts and consumer advocates on drug safety and… read more
The Senate Health, Education, Labor and Pensions Committee heard testimony from medical experts and consumer advocates on drug safety and the approval process for new drugs. Among the topics they addressed were current controversies around the COX-2 inhibitor drugs that were removed from the market after public health safety concerns were raised about their use. Witnesses also examined the lessons learned from those controversies and possible methods to improve drug safety and operations at the FDA. No specific legislative proposals were addressed during the hearing. close
People in this video
More PeopleHosting Organization
Related Video
-
Department of Labor and Food and Drug Administration Confirmations Hearing
Committee members heard testimony from Andrew von Eschenbach on his nomination to be commissioner of the Food and Drug…
-
Prescription Drug Safety
Food and Drug Administration Commissioner Andrew C. von Eschenbach talked about efforts to balance drug safety, risk,…
-
Food Safety
Witnesses testified about food safety. This hearing was held after a report to the Food and Drug Administration (FDA)…
-
FDA Oversight
Anna Edney talked about the responsibilities of the Food and Drug Administration (FDA) and the role of Congressional…